In eukaryocyte cells the DNA polymerase is not able to terminate the duplication of the DNA for the entire length of the chromatid ®lament. 1 Chromosomes terminate with sequences of repetitive bases, called telomeres, which do not codify for mRNA. When telomeres shorten below a critical threshold, signals of damage to the DNA are sent which stop cell division. 2 In embryonic and adult staminal cells the enzyme telomerase maintains telomere length at the end of DNA-duplication cycles.
1,2 Telomerase is absent in most differentiated cells, but may become re-activated in many cancers. Prostate carcinomas usually show short telomeres and active telomerase. 3, 4 According to a recent study, 5 92% of prostate carcinomas showed evidence of telomerase activity, as did most PINs (73%), particularly if adjacent to neoplasia. Telomerasic activity is not usually found in non-malignant prostatic tissues, suggesting that the search for telomerase activity may improve the procedure of diagnosis in biopsies.
Method
Using a method of sampling developed in our laboratory, we detected the presence of telomerasic activity in cells collected from prostatic biopsies without altering the tissue sample for histological examination. 6 To collect cells, the fresh biopsy is apposed on a small area of an RNAse-free glass slide, which is immediately frozen in dry ice. The biopsy is then ®xed in 10% buffered formalin for routine pathological examination. The procedure includes the use of a lysis buffer to extract the enzyme, centrifugation to deposit residue and DNA, incubation of a supernatant with labelled DNA primers to produce fragments of telomeres (TRAP method), and polymerase chain reaction (PCR) ampli®cation of the telomeric DNA evaluated by autoradiography or, more recently, the use of telomerase PCR ELISA. At present, 41 patients (average age 71 y) have been recruited into this study and submitted to prostate mapping after standard prostate evaluation (DRE, total and free prostate-speci®c antigen determination and TRUS).
Results
Of the 25 biopsies diagnosed as adenocarcinomas, 21 were positive for telomerase. Of the 12 cases which were negative for cancer and considered histologically to be benign adenomatous hyperplasia, two were positive for telomerase. Two of the four cases evaluated as PINs showed telomerasic activity. The prostatic biopsies telomerase detection test has reached a good reproducibility, particularly with the PCR ELISA kit.
Conclusion
The data obtained, which are currently being analysed, do not allow us to draw statistically signi®cant conclusions. It must be emphasized, however, that this study indicated that the possibility exists of using the telomerase evaluation for diagnosing prostate cancer without minimally distorting tissue structure for histological evaluation. In addition to a greater numerical sampling and further improvements in methodology (such as hybridisation in situ, we forsee the correlation of the presence of telomerase to the proliferation and degree of cell differentiation. Concerning the availability of surgical specimens, we anticipate extending the correlation to other clinical±pathological parameters.
